Mexico’s 2013–2014 energy reform promises to bring the country’s economic drivers and regulatory institutions in line with the global practices of free market democracies. If successful, this development would be a 180-degree turn. The accomplishment of such realignment is hardly assured, however.
Cancer drug shortages are almost uniquely associated with generic drugs (small profit margins) and rarely with patented drugs (large profit margins). They are common in the U.S., but uncommon in Europe and elsewhere, where generic drug prices are on average higher than in the U.S. This suggests the main cause of drug shortages is economic.
Despite mounting efforts toward achieving gender equality, the MENA region continues to rank the lowest worldwide in women’s economic participation and opportunity.
The situation in Ukraine is the most serious foreign policy challenge ever faced by the Obama administration, writes Rice faculty scholar Richard Stoll.
Erika de la Garza, program director of the Latin America Initiative, discusses the political fragmentation and need for coalition building in Costa Rica, where the recent presidential election resulted in a runoff.
On Monday, three committees in Mexico’s senate — constitutional issues, energy and legislative studies — voted to bring an energy reform bill to the chamber’s floor for debate. The legislation would provide international oil companies the opportunity to participate in profit-sharing contracts and concession-like licenses for energy operations in Mexico, and it is expected to become law by the end of the legislative session Dec. 15.